Gloves with a double barrier function and perforation indicator help reduce the risk of injury and infection

MedTech startup Smarterials Technology closes second seed financing round

29-Sep-2021 - Germany

Smarterials Technology GmbH has successfully closed its second round of financing. Led by High-Tech Gründerfonds (HTGF), pre-seed investors Think.Health Ventures and Emanet also invest a total of nearly €1 million in the Berlin-based company. The new funding will be used to complete final development steps and prepare production for the mass market.

Dr. Martin Bothe, Michael Schneiker, Dr. Nikolaus Mirtschin, co-founders of Smarterials Technology (from left to right)

Smarterials Technology develops surgical gloves based on innovative materials with a double barrier function and perforation indicator that help reduce the risk of injury and infection among healthcare workers. This novel product helps to avoid follow-up costs due to contamination with potentially infectious foreign blood – an estimated 500,000 cases with follow-up costs of up to 1,600 euros per case in Germany alone. In addition, the double-layer gloves speed up the donning process and thus improve the workflow in hospitals and care facilities.

The team of Smarterials was also able to convince the EU Commission of its innovative product and is receiving grants of 1.85 million euros as part of the Horizon 2020 SME Instrument (Phase II) funding program.

"A lot has happened in the medical glove market during the Corona pandemic. With the capital provided, we are able to take advantage of the dynamics of the situation and scale our product. Our Two-in-One Gloves replace the current safety standard while reducing the consumption of materials and energy and contributing to the conservation of natural resources. Our goal is to make Two-in-One Gloves the global standard in the surgical field", said Dr. Martin Bothe, co-founder and CEO of Smarterials Technology.

"We believe in Smarterials‘ technology to be the future in safety gloves for medical personnel to provide safety for both doctors and patients. The perspective to address a mass market rather quickly was the final convincing argument for our investment", said Dr. Fabian Mohr, Senior Investment Manager at High-Tech Gründerfonds.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

Something is happening in the life science industry ...

This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.